Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermittent Hypoxia-hyperoxia Conditioning as a New Therapeutic Intervention to Reduce Hypertension

NCT05603676 is registered in ClinicalTrials.gov with Gregoire Millet as lead sponsor.

NCT NCT05603676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05603676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermittent Hypoxia-hyperoxia Conditioning as a New Therapeutic Intervention to Reduce Hypertension
Lead sponsor
Gregoire Millet
Phase
Not applicable
Overall status
Unknown status
Start date
November 15, 2022
Completion date
May 15, 2023
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension